The three new candidate biomarkers SAA, PROZ, and C4BPB were validated by ELISA in 136 patients with TB, 66 healthy controls, 72 patients with pneumonia, and 72 patients with COPD. Here, PROZ is linked to chronic obstructive pulmonary disease.